Aromatic or modified aromatic: — Other: — Drugs
Part of: 293499 — Other: — Other:
N357497 · 2026-02-03 — The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
Elinzanetant is a neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist that acts on the central nervous system (CNS). It is indicated for the treatment of moderate to severe vasomotor symptoms (VMS; also known as hot flashes) associated with menopause or endocrine therapy (ET) for breast cancer. Lynkuet, imported in 60 mg capsule form, is a neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist. It is indicated as an alternative to hormonal replacement therapy for women who cannot use hormone-based treatments for the treatment of moderate to severe vasomotor symptoms, commonly…
N354921 · 2025-11-12 — The tariff classification of Terazosin Hydrochloride Anhydrous (CAS No. 63074-08-8) in bulk form, from Germany
Terazosin Hydrochloride Anhydrous is an alpha-1 adrenergic antagonist. It is indicated for the treatment of benign prostatic hyperplasia (BPH) and hypertension. The applicable subheading for the Terazosin Hydrochloride Anhydrous in bulk form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Effective April 5, 2025, Executive…
N353870 · 2025-10-16 — The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
Cabotegravir is an antiretroviral drug indicated for the treatment of HIV infection. It is an inhibitor of HIV integrase, which reduces viral replication. The applicable subheading for the Cabotegravir in bulk powder form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.” The general rate of duty will be 6.5 percent ad valorem. Currently, Cabotegravir is not listed in the Pharmaceutical…
N339908 · 2024-05-30 — The tariff classification of Ozanimod (CAS No. 1306760-87-1) in bulk form, from Taiwan
, Ltd. Ozanimod is a sphingosine l-phosphate receptor modulator. It is an immunomodulatory drug indicated for the treatment of multiple sclerosis, ulcerative colitis, and inflammatory bowel disease. The applicable subheading for the Ozanimod in bulk form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.” The rate of duty will be 6.5 percent ad valorem. Currently, Ozanimod is not listed in the…
N337860 · 2024-02-21 — The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
Cabotegravir is an antiretroviral drug indicated for the treatment of HIV infection. It is an inhibitor of HIV integrase, which reduces viral replication. The applicable subheading for the Cabotegravir in bulk powder form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.” The rate of duty will be 6.5 percent ad valorem. Currently, Cabotegravir is not listed in the Pharmaceutical Appendix to…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product